COVID-19 Pnömonili İki Hastada Plörektomi/Dekortikasyon Ameliyatı Sonrası Artan Uzamış Hava Kaçağı

Yıl 2024, Cilt: 6 Sayı: 1, 37 - 39, 01.03.2024

Merve Şatır , İsmail Tombul , Muhammet Sayan , Ali Çelik , Abdullah Taştepe

https://doi.org/10.38175/phnx.1231855

Öz

Malign plevral mezotelyomada uygun klinik evre ve medikal kondisyonlu hastalarda cerrahi tedavi, multimodal tedavinin bir parçasıdır. Plörektomi-dekortikasyon yöntemi, mezotelyoma için uygulanan cerrahilerden biridir ve bu yöntemdeki korkulan morbidite uzamış hava kaçağıdır. Uzamış hava kaçağında tüp torakostomi süresi de uzamakta ve buna bağlı komplikasyon riski de artmaktadır. COVID-19 pnömonisinde abartılı inflamasyon sonucu gelişen plevral yapışıklıklar ve alvelollerdeki yırtılmaya yatkınlık artışı gibi sebeplerle bu komplikasyonda artış beklenen bir durumdur. Burada malign plevral mezotelyoma tanısıyla indüksiyon tedavisi sonrası cerrahi planlanan ve hazırlık sürecinde COVID-19 pnömonisi gelişen 2 olguda, plörektomi-dekortikasyon ameliyatı sonrası uzamış hava kaçağı ve uzamış tüp torakostomi tedavisi sunulmuştur.

Anahtar Kelimeler

COVID-19, Maling plevral mezotelioma, Uzamış hava kaçağı

Prolonged Air Leak After Pleurectomy/Decortication Surgery in Two Patients with COVID-19 Pneumonia

Öz

Surgical treatment is a part of multimodal treatment in patients with malignant pleural mesothelioma in appropriate clinical stage and medical condition. The pleurectomy/decortication is a surgical technique for mesothelioma and its challenging morbidity is prolonged air leak. In case of prolonged air leakage, both the duration of tube thoracostomy and the risk of its complications increase. An increase in this complication is expected due to reasons such as pleural adhesions developing as a result of exaggerated inflammation in COVID-19 pneumonia and increased susceptibility to tearing in the alveoli. Here, we present the treatment of prolonged air leak after pleurectomy-decortication surgery in 2 cases of malignant pleural mesothelioma who were scheduled for surgery after induction therapy and who developed COVID-19 pneumonia during the preparation process.

Anahtar Kelimeler

COVID-19;, malignant pleural mesothelioma, prolonged air leak

Kaynakça

• Bueno R, Opitz I; IASLC Mesothelioma Taskforce. Surgery in Malignant Pleural Mesothelioma. J Thorac Oncol. 2018;13(11):1638-1654. doi: 10.1016/j.jtho.2018.08.001.
• Batirel HF. Extrapleural pneumonectomy (EPP) vs. pleurectomy decortication (P/D). Ann Transl Med. 2017;5(11):232. doi: 10.21037/atm.2017.03.82.
• Scherpereel A, Opitz I, Berghmans T, Psallidas I, Glatzer M, Rigau D, et al. ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma. European Respiratory Journal. 2020;55 (6) 1900953; DOI: 10.1183/13993003.00953-2019.
• Tessitore A, Patella M, Giuliani M, Theologou T, Freguia S, Minerva EM, et al. Surgical treatment of pleural empyema in Coronavirus disease 19 patients: the Southern Switzerland experience. Interact Cardiovasc Thorac Surg. 2020;22:ivaa269. doi: 10.1093/icvts/ivaa269.
• Dietz M, Chironi G, Claessens YE, Farhad RL, Rouquette I, Serrano B, et al. COVID-19 pneumonia: relationship between inflammation assessed by whole-body FDG PET/CT and short-term clinical outcome. Eur J Nucl Med Mol Imaging 2021;48, 260–268. https://doi.org/10.1007/s00259-020-04968-8.
• Wei XS, Wang X, Ye LL, Niu YR, Peng WB, Wang ZH, et al. Pleural effusion as an indicator for the poor prognosis of COVID-19 patients. Int J Clin Pract. 2021;1:e14123. doi: 10.1111/ijcp.14123.
• Mahmudpour M, Roozbeh J, Keshavarz M, Farrokhi S, Nabipour I. COVID-19 cytokine storm: The anger of inflammation. Cytokine. 2020;133:155151. doi:10.1016/j.cyto.2020.155151.
• Hameed M, Jamal W, Yousaf M, Thomas M, Haq IU, Ahmed Set al. Pneumothorax In Covid-19 Pneumonia: A case series. Respir Med Case Rep. 2020;31:101265. doi: 10.1016/j.rmcr.2020.101265.
• Friedberg JS, Simone CB 2nd, Culligan MJ, Barsky AR, Doucette A, McNulty S, Hahn SM, Alley E, Sterman DH, Glatstein E, Cengel KA. Extended Pleurectomy-Decortication-Based Treatment for Advanced Stage Epithelial Mesothelioma Yielding a Median Survival of Nearly Three Years. Ann Thorac Surg. 2017;103(3):912-919. doi: 10.1016/j.athoracsur.2016.08.071.
• Hashimoto M, Yamamoto H, Endo S, Okada M, Miyata H, Hasegawa S, Chida M. Japanese Current Status of Curative-Intent Surgery for Malignant Pleural Mesothelioma. Ann Thorac Surg. 2021; 27:S0003-4975(21)00754-2. doi: 10.1016/j.athoracsur.2021.04.042.
• Kesieme EB, Dongo A, Ezemba N, Irekpita E, Jebbin N, Kesieme C. Tube thoracostomy: complications and its management. Pulm Med. 2012;2012:256878. doi: 10.1155/2012/256878.